November 16–18, 2008; National Harbor, MD, Abstracts: Thirty-First CTRC-AACR San Antonio Breast Cancer Symposium November 15–19, 2009; Boston, MA, Abstracts: AACR International Conference on Frontiers in Cancer Prevention Research December 8–12, 2015; San Antonio, TX, Abstracts: Third AACR–IASLC Joint Conference on Molecular Origins of Lung Cancer In this interview, Digital Editor Tristan Free speaks to Elaine Mardis about the challenges of switching the meeting online, what she learned from the process and some of the biggest obstacles currently facing cancer research. September 18–21, 2011; Washington, DC, Abstracts: AACR International Conference on Frontiers in Cancer Prevention Research May 8–11, 2019; San Diego, CA, Abstracts: AACR Special Conference on Bladder Cancer: Transforming the Field February 19–22, 2019; San Diego, CA, Proceedings: AACR Annual Meeting 2019 Wenn Sie alle nicht erforderlichen Cookies ablehnen möchten, können Sie auf unserer Website mit den unbedingt erforderlichen Cookies surfen. Date: 07/28/2020 From left, Luca Falzone, University of Catania, Italy; Rogier J. Nell, Leiden University Medical Center; and Ekaterina Kuligina, NN Petrov Research Institute of Oncology in St. Petersburg, Russia. Presentations and Poster Sessions Featuring NCI Staff. September 20–23, 2019; San Francisco, CA, Abstracts: AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics April 1–5, 2006; Washington DC, Abstracts: First AACR International Conference on Molecular Diagnostics in Cancer Therapeutic Development; Sep 12–15, 2006, Abstracts: Fifth AACR International Conference on Frontiers in Cancer Prevention Research Utilizing targeted, deep coverage next-generation sequencing data (MSK-IMPACT) to identify clonal hematopoiesis-related mutations, we show that patients previously treated with oncologic therapy have increased rates of clonal hematopoiesis, with increased mutation frequency in DNA damage response-related genes. Evolution to Metastatic Disease, Oncologic therapy shapes the fitness landscape of clonal hematopoiesis. This presentation will also examine how the AACR Project Genomics Evidence Neoplasia Information Exchange (GENIE) was utilized for evaluating meta-knowledgebase value. April 2–6, 2011; Orlando, FL, Abstracts: Second AACR International Conference on Frontiers in Basic Cancer Research September 30–October 3, 2018; New York, NY, Abstracts: Eleventh AACR Conference on The Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved Katarzyna (Kasia) Bourcier, PhD, National Institute of Allergy and Infectious Diseases Dr. Kasia Bourcier obtained a PhD in Biomedical … Copyright © 2020 by the American Association for Cancer Research. April 29–30, 2019; Austin, TX, Abstracts: AACR Special Conference on the Hippo Pathway: Signaling, Cancer, and Beyond December 3–6, 2017; Atlanta, GA, Abstracts: 2017 San Antonio Breast Cancer Symposium November 8–11, 2012; Miami, FL, Abstracts: Thirty-Fifth Annual CTRC-AACR San Antonio Breast Cancer Symposium October 1–4, 2017; Boston, MA, Abstracts: AACR Special Conference: Addressing Critical Questions in Ovarian Cancer Research and Treatment zur Kasse gehen. June 27–30, 2012; Boston, MA, Abstracts: AACR Special Conference on Pancreatic Cancer: Progress and Challenges Philadelphia, PA 19106-4404  USA October 22–26, 2007; San Francisco, CA, Abstracts: AACR Centennial Conference: Translational Cancer Medicine In addition to these studies, several related studies presented at AACR further highlighted research being done to leverage ddPCR to explore the utility of miRNA-based and epigenetic biomarkers: For further details about these presentations, and to view the virtual show, please visit the AACR virtual meeting programs: “Meeting I” and “Meeting II.” To learn more about Bio-Rad’s ddPCR technology, visit bio-rad.com/digitalPCR. May 12–15, 2016; Orlando, FL, Abstracts: AACR Precision Medicine Series: Targeting the Vulnerabilities of Cancer March 29–April 3, 2019; Atlanta, GA, Abstracts: AACR-AHNS Head and Neck Cancer Conference: Optimizing Survival and Quality of Life through Basic, Clinical, and Translational Research April 1–5, 2017; Washington, DC, Abstracts: AACR-AHNS Head and Neck Cancer Conference: Optimizing Survival and Quality of Life through Basic, Clinical, and Translational Research January 18–22, 2017; Cape Town, South Africa, Proceedings: AACR Annual Meeting 2017 This poster (abstract 4836) was presented Monday, June 22, 9 AM-6 PM. October 26–30, 2019; Boston, MA, Abstracts: AACR Special Conference on Tumor Immunology and Immunotherapy Further study of binimetinib in tumors with codon 61 mutations may be warranted. The 2020 American Association for Cancer Research (AACR) annual meeting is being held virtually in April and June. Preclinical and clinical data have suggested that downstream inhibition with a MEK inhibitor, such as binimetinib, might be efficacious for NRAS-mutated cancers. February 3–6, 2009; Carefree, AZ, Proceedings: AACR 100th Annual Meeting 2009 December 10–14, 2013; San Antonio, TX, Abstracts: Sixth AACR Conference: The Science of Cancer Health Disparities October 27–30, 2013; National Harbor, MD, Abstracts: AACR Special Conference: Pediatric Cancer at the Crossroads: Translating Discovery into Improved Outcomes Impressum | November 27–30, 2018; Miami Beach, FL, Abstracts: 2018 San Antonio Breast Cancer Symposium February 28–March 2, 2016; Orlando, FL, Proceedings: AACR 107th Annual Meeting 2016 February 21–24, 2020; Orlando, FL, Abstracts: AACR Special Conference on the Evolving Landscape of Cancer Modeling Register your new instrument - get 3 months extra warranty for free, The next iteration in the Bio-Rad tradition of quantitative PCR (qPCR) excellence. Weitere Informationen zur Verwendung von Cookies finden Sie in unserer Cookie-Richtlinie. October 27–30, 2016; San Francisco, CA, Abstracts: AACR Special Conference on DNA Repair: Tumor Development and Therapeutic Response The session will be held Thursday, June 25 at 1:00 p.m. EDT. Elaine Mardis on taking AACR 2020 online, key challenges and the fields to watch in cancer research. These forward-looking statements include, without limitation, statements we make regarding our expectations about our products. In this interview, Digital Editor Tristan Free speaks to Elaine Mardis about the challenges of switching the meeting online, what she learned from the process and some of … Select "Patients / Caregivers / Public" or "Researchers / Professionals" to filter your results. Learn how this trial tested novel, humanized bispecific CD19/CD22 CAR T cells, developed to overcome resistance with approved CAR T-cell therapies, in patients with relapsed/refractory acute B-cell lymphoblastic leukemia. Building off preliminary studies that identified miRNAs associated with the disease, researchers used miRNA TaqMan probes and ddPCR technology to determine the expression levels of the miRNAs in plasma and matched saliva samples. April 23–25, 2017; San Diego, CA, Abstracts: Second AACR Conference on Hematologic Malignancies: Translating Discoveries to Novel Therapies April 18–22, 2015; Philadelphia, PA, Abstracts: AACR Special Conference: Advances in Brain Cancer Research Forward-looking statements generally can be identified by the use of forward-looking terminology such as "plan", "believe," "expect," "anticipate," "may," "will," "intend," "estimate," "continue," or similar expressions or the negative of those terms or expressions, although not all forward-looking statements contain these words. February 8–11, 2015; San Francisco, CA, Abstracts: AACR-SNMMI Joint Conference: State-of-the-Art Molecular Imaging in Cancer Biology and Therapy Alignment of TMB measured on clinical samples: Phase IIB of the Friends of Cancer Research TMB Harmonization Project. “With the technology’s high sensitivity and precision, we were able to quantify small changes in the expression of certain miRNAs that might predict the presence of tumors or inform a patient’s prognosis.”. January 8–11, 2012; San Diego, CA, Abstracts: AACR Special Conference on Noncoding RNAs and Cancer We use cookies to ensure that we give you the best experience on our website. You will be able to view the Virtual Meeting as long as you use a supported browser. 3DHISTECH will participate at the Virtual AACR 2020 on June 22-24. Datenschutz Unbedingt erforderliche Cookies (erforderlich)Wir verwenden unbedingt erforderliche Cookies, damit unsere Website funktioniert und beispielsweise Netzwerkübertragungen ausführt, die Sicherheit erfüllt und den Zugriff ermöglicht sowie Ihre Cookie-Einstellungen und die Waren, die Sie kaufen möchten, speichert, wenn Sie diese Ihrem Warenkorb hinzufügen bzw. March 23-24, 2020. Bevor Sie uns besuchen, möchten wir Sie darüber informieren, dass wir zu verschiedenen Zwecken Cookies verwenden, einschließlich dazu, Ihre Einstellungen zu speichern und Ihnen ein besseres Surferlebnis zu bieten. Elaine Mardis on taking AACR 2020 online, key challenges and the fields to watch in cancer research. March 2–5, 2020; San Diego, CA, Proceedings: AACR Annual Meeting 2020 December 5–8, 2007; Philadelphia, PA, Proceedings: AACR 97th Annual Meeting 2006 January 29–February 1, 2014; San Diego, CA, Abstracts: AACR Special Conference on RAS Oncogenes: From Biology to Therapy A comprehensive list of COVID-related resources from NCI is available at COVID-19 Information for Cancer Researchers. Please Note: All session times for the AACR Virtual Annual Meeting II are U.S. Eastern Daylight Time (EDT). For more information, please visit bio-rad.com. April 16–20, 2005; Anaheim CA, Proceedings: AACR 95th Annual Meeting 2004 March 31–April 4, 2012; Chicago, IL, Abstracts: AACR Special Conference Molecularly Targeted Therapies: Mechanisms of Resistance Kuligina and her team examined nearly 500 blood samples from approximately 100 patients with various types of cancer. September 24–27, 2017; Orlando, Florida, Abstracts: Tenth AACR Conference on The Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved January 4–7, 2016; San Diego, CA, Abstracts: AACR Special Conference: The Function of Tumor Microenvironment in Cancer Progression October 1–4, 2017; Pittsburgh, PA, Abstracts: AACR Special Conference: Advances in Breast Cancer Research “Our work has shown that the presence of ctDNA in plasma is very specific to patients who experience clinical progression of tumor disease,” said Kuligina. While the trial did not meet the primary endpoint (RR=2.1%), it was noted that patients whose tumors harbored the codon 61 mutation had a significantly longer OS (p=0.04) and PFS (p=0.006) than those with tumors harboring codon 12 or 13 NRAS-mutations. March 27–31, 2004; Orlando FL, American Association for Cancer Research November 2–5, 2016; Montreal, QC, Canada, Abstracts: AACR Special Conference: Improving Cancer Risk Prediction for Prevention and Early Detection September 17–20, 2016; Tampa, FL, Abstracts: Ninth AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved With the increasing use of ddPCR technology-based diagnostics in the clinic, Ekaterina Kuligina, PhD of the Department of Tumor Biology at the NN Petrov Research Institute of Oncology in St. Petersburg, Russia, wanted to see if environmental variables would independently impact the results.